DNA Past Earnings image   This DNA past earnings page last updated 11/16/2022
DNA Past Earnings
PeriodPast Earnings DateGAAP
Q3 202211/14/2022-0.410
Q2 20228/15/2022-0.410
Q1 20225/16/2022-0.380
Q4 20213/28/2022-0.020
Q3 202111/15/2021-0.070
DNA Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/14/20220.07B
Q2 20228/15/20220.14B
Q1 20225/16/20220.17B
Q4 20213/28/20220.15B
Q3 202111/15/20210.08B
Quotes delayed 20 minutes

Email EnvelopeFree DNA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Ginkgo Bioworks Holdings (DNA) is categorized under the Miscellaneous sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

DOOR Past Earnings
DSEY Past Earnings
EFTR Past Earnings
ELMS Past Earnings
EMBK Past Earnings
ENJY Past Earnings
ENSC Past Earnings
ENVX Past Earnings
EPSN Past Earnings
EQRX Past Earnings

DNA Past Earnings Q&A

What was the best and worst DNA past earnings results?
For Ginkgo Bioworks Holdings, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest DNA past earnings result in our data set was -0.020/share posted in Q4 2021, while the lowest was in Q3 2022 when DNA posted -0.410/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2022 when DNA reported 0.17B in revenue, while the quarter with the lowest revenue in our data set was Q3 2022 at 0.07B of revenue.

  Suggested answer: There are 5 DNA past earnings results in our data set.

On this page we presented the DNA past earnings date information for Ginkgo Bioworks Holdings. Reviewing that DNA Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2021, when DNA posted gaap of -0.020/share. Meanwhile the lowest DNA past earnings result was in Q3 2022, when DNA posted gaap of -0.410/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2022 when DNA reported 0.17B in revenue, while the smallest revenue quarter was Q3 2022 when DNA reported 0.07B in revenue.

Any self directed investor doing their due diligence on DNA or any other given stock can benefit from researching all of the Ginkgo Bioworks Holdings past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Ginkgo Bioworks Holdings past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for DNA. Thanks for visiting, and the next time you need to research DNA past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: PAHC Dividend History, Institutional Holders of DRTX, FMIV YTD Return.


DNA Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.